Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

[« Heated » tobacco products : what do you need to know ?]

Berthet A, Jacot Sadowski I, Zürcher K, Guenin V, Gendre A, Auer R, Vernez D, Cornuz J.

Rev Med Suisse. 2018 Oct 31;14(625):1935-1941. French.

PMID:
30379475
2.

Glu-C, an alternative digestive enzyme for the quantitative LC-MS/MS analysis of an IgG-based antibody biotherapeutic.

Hansen K, Szarka S, Escoffier E, Berthet A, Venet J, Collet-Brose J, Hepburn S, Wright M, Wheller R, Nelson R, Kay RG.

Bioanalysis. 2018 Jul 1;10(13):997-1007. doi: 10.4155/bio-2017-0259. Epub 2018 Jul 4.

PMID:
29972309
3.

Occupational exposure to plant protection products and health effects in Switzerland: what do we know and what do we need to do?

Graczyk H, Hopf NB, Mediouni Z, Guseva-Canu I, Sanvido O, Schmid K, Berthet A.

Swiss Med Wkly. 2018 Apr 26;148:w14610. doi: 10.4414/smw.2018.14610. eCollection 2018.

4.

Polycyclic aromatic hydrocarbons (PAHs) skin permeation rates change with simultaneous exposures to solar ultraviolet radiation (UV-S).

Hopf NB, Spring P, Hirt-Burri N, Jimenez S, Sutter B, Vernez D, Berthet A.

Toxicol Lett. 2018 May 1;287:122-130. doi: 10.1016/j.toxlet.2018.01.024. Epub 2018 Feb 2.

PMID:
29410274
5.

Perplexing Conclusions Concerning Heat-Not-Burn Tobacco Cigarettes-Reply.

Auer R, Cornuz J, Berthet A.

JAMA Intern Med. 2017 Nov 1;177(11):1699-1700. doi: 10.1001/jamainternmed.2017.5861. No abstract available.

PMID:
29114801
6.

Heat-Not-Burn Tobacco Cigarettes: Smoke by Any Other Name.

Auer R, Concha-Lozano N, Jacot-Sadowski I, Cornuz J, Berthet A.

JAMA Intern Med. 2017 Jul 1;177(7):1050-1052. doi: 10.1001/jamainternmed.2017.1419. No abstract available.

7.

Ex vivo human skin permeation of methylchloroisothiazolinone (MCI) and methylisothiazolinone (MI).

Berthet A, Spring P, Vernez D, Plateel G, Hopf NB.

Arch Toxicol. 2017 Nov;91(11):3529-3542. doi: 10.1007/s00204-017-1978-x. Epub 2017 May 3.

PMID:
28470404
8.

Loss of α-Synuclein Does Not Affect Mitochondrial Bioenergetics in Rodent Neurons.

Pathak D, Berthet A, Bendor JT, Yu K, Sellnow RC, Orr AL, Nguyen MK, Edwards RH, Manfredsson FP, Nakamura K.

eNeuro. 2017 Apr 28;4(2). pii: ENEURO.0216-16.2017. doi: 10.1523/ENEURO.0216-16.2017. eCollection 2017 Mar-Apr.

9.

Effectiveness of hand washing on the removal of iron oxide nanoparticles from human skin ex vivo.

Lewinski NA, Berthet A, Maurizi L, Eisenbeis A, Hopf NB.

J Occup Environ Hyg. 2017 Aug;14(8):D115-D119. doi: 10.1080/15459624.2017.1296238.

PMID:
28426382
10.

A systematic review of passive exposure to cannabis.

Berthet A, De Cesare M, Favrat B, Sporkert F, Augsburger M, Thomas A, Giroud C.

Forensic Sci Int. 2016 Dec;269:97-112. doi: 10.1016/j.forsciint.2016.11.017. Epub 2016 Nov 16. Review.

11.

In Vitro and In Vivo Effectiveness of an Innovative Silver-Copper Nanoparticle Coating of Catheters To Prevent Methicillin-Resistant Staphylococcus aureus Infection.

Ballo MK, Rtimi S, Pulgarin C, Hopf N, Berthet A, Kiwi J, Moreillon P, Entenza JM, Bizzini A.

Antimicrob Agents Chemother. 2016 Aug 22;60(9):5349-56. doi: 10.1128/AAC.00959-16. Print 2016 Sep.

12.

Drug vaping applied to cannabis: Is "Cannavaping" a therapeutic alternative to marijuana?

Varlet V, Concha-Lozano N, Berthet A, Plateel G, Favrat B, De Cesare M, Lauer E, Augsburger M, Thomas A, Giroud C.

Sci Rep. 2016 May 26;6:25599. doi: 10.1038/srep25599.

13.

[Biomonitoring information management and communication: an ethical and interdisciplinary perspective].

Pralong L, Berthet A, Vernez D, Hopf NB, Benaroyo L.

Rev Med Suisse. 2015 Dec 16;11(499):2400-3. French.

PMID:
26852557
14.

E-Cigarettes: A Review of New Trends in Cannabis Use.

Giroud C, de Cesare M, Berthet A, Varlet V, Concha-Lozano N, Favrat B.

Int J Environ Res Public Health. 2015 Aug 21;12(8):9988-10008. doi: 10.3390/ijerph120809988. Review.

15.

Dynamin-related protein 1 is required for normal mitochondrial bioenergetic and synaptic function in CA1 hippocampal neurons.

Shields LY, Kim H, Zhu L, Haddad D, Berthet A, Pathak D, Lam M, Ponnusamy R, Diaz-Ramirez LG, Gill TM, Sesaki H, Mucke L, Nakamura K.

Cell Death Dis. 2015 Apr 16;6:e1725. doi: 10.1038/cddis.2015.94.

16.

Loss of mitochondrial fission depletes axonal mitochondria in midbrain dopamine neurons.

Berthet A, Margolis EB, Zhang J, Hsieh I, Zhang J, Hnasko TS, Ahmad J, Edwards RH, Sesaki H, Huang EJ, Nakamura K.

J Neurosci. 2014 Oct 22;34(43):14304-17. doi: 10.1523/JNEUROSCI.0930-14.2014.

17.

A new alternative method for testing skin irritation using a human skin model: a pilot study.

Miles A, Berthet A, Hopf NB, Gilliet M, Raffoul W, Vernez D, Spring P.

Toxicol In Vitro. 2014 Mar;28(2):240-7. doi: 10.1016/j.tiv.2013.10.022. Epub 2013 Nov 7.

PMID:
24211334
18.

Skin permeation and metabolism of di(2-ethylhexyl) phthalate (DEHP).

Hopf NB, Berthet A, Vernez D, Langard E, Spring P, Gaudin R.

Toxicol Lett. 2014 Jan 3;224(1):47-53. doi: 10.1016/j.toxlet.2013.10.004. Epub 2013 Oct 16.

PMID:
24140552
19.

Energy failure: does it contribute to neurodegeneration?

Pathak D, Berthet A, Nakamura K.

Ann Neurol. 2013 Oct;74(4):506-16. doi: 10.1002/ana.24014. Review.

20.

A neo-substrate that amplifies catalytic activity of parkinson's-disease-related kinase PINK1.

Hertz NT, Berthet A, Sos ML, Thorn KS, Burlingame AL, Nakamura K, Shokat KM.

Cell. 2013 Aug 15;154(4):737-47. doi: 10.1016/j.cell.2013.07.030.

21.

Human skin in vitro permeation of bentazon and isoproturon formulations with or without protective clothing suit.

Berthet A, Hopf NB, Miles A, Spring P, Charrière N, Garrigou A, Baldi I, Vernez D.

Arch Toxicol. 2014 Jan;88(1):77-88. doi: 10.1007/s00204-013-1087-4. Epub 2013 Jul 3.

22.

PSD-95 expression controls L-DOPA dyskinesia through dopamine D1 receptor trafficking.

Porras G, Berthet A, Dehay B, Li Q, Ladepeche L, Normand E, Dovero S, Martinez A, Doudnikoff E, Martin-Négrier ML, Chuan Q, Bloch B, Choquet D, Boué-Grabot E, Groc L, Bezard E.

J Clin Invest. 2012 Nov;122(11):3977-89. doi: 10.1172/JCI59426. Epub 2012 Oct 8.

23.

A detailed urinary excretion time course study of captan and folpet biomarkers in workers for the estimation of dose, main route-of-entry and most appropriate sampling and analysis strategies.

Berthet A, Heredia-Ortiz R, Vernez D, Danuser B, Bouchard M.

Ann Occup Hyg. 2012 Aug;56(7):815-28. doi: 10.1093/annhyg/mes011. Epub 2012 Mar 16.

PMID:
22425654
24.

Effect of age on toxicokinetics among human volunteers exposed to propylene glycol methyl ether (PGME).

Hopf NB, Vernez D, Berthet A, Charriere N, Arnoux C, Tomicic C.

Toxicol Lett. 2012 May 20;211(1):77-84. doi: 10.1016/j.toxlet.2012.02.018. Epub 2012 Mar 6.

PMID:
22421272
25.

L-DOPA impairs proteasome activity in parkinsonism through D1 dopamine receptor.

Berthet A, Bezard E, Porras G, Fasano S, Barroso-Chinea P, Dehay B, Martinez A, Thiolat ML, Nosten-Bertrand M, Giros B, Baufreton J, Li Q, Bloch B, Martin-Negrier ML.

J Neurosci. 2012 Jan 11;32(2):681-91. doi: 10.1523/JNEUROSCI.1541-11.2012.

26.

Toxicokinetic modeling of folpet fungicide and its ring-biomarkers of exposure in humans.

Heredia-Ortiz R, Berthet A, Bouchard M.

J Appl Toxicol. 2013 Jul;33(7):607-17. doi: 10.1002/jat.1782. Epub 2011 Dec 19.

PMID:
22180346
27.

Endogenous morphine-like compound immunoreactivity increases in parkinsonism.

Charron G, Doudnikoff E, Laux A, Berthet A, Porras G, Canron MH, Barroso-Chinea P, Li Q, Qin C, Nosten-Bertrand M, Giros B, Delalande F, Van Dorsselaer A, Vital A, Goumon Y, Bezard E.

Brain. 2011 Aug;134(Pt 8):2321-38. doi: 10.1093/brain/awr166. Epub 2011 Jul 8.

PMID:
21742735
28.

Toxicokinetics of captan and folpet biomarkers in dermally exposed volunteers.

Berthet A, Bouchard M, Vernez D.

J Appl Toxicol. 2012 Mar;32(3):202-9. doi: 10.1002/jat.1659. Epub 2011 Mar 5.

PMID:
21381058
29.

Toxicokinetics of captan and folpet biomarkers in orally exposed volunteers.

Berthet A, Bouchard M, Danuser B.

J Appl Toxicol. 2012 Mar;32(3):194-201. doi: 10.1002/jat.1653. Epub 2011 Mar 5.

PMID:
21381057
30.

Gas-chromatography mass-spectrometry determination of phthalic acid in human urine as a biomarker of folpet exposure.

Berthet A, Berode M, Bouchard M.

Anal Bioanal Chem. 2011 Apr;400(2):493-502. doi: 10.1007/s00216-011-4753-5. Epub 2011 Feb 20.

PMID:
21336936
31.

Liquid chromatography-tandem mass spectrometry (LC/APCI-MS/MS) methods for the quantification of captan and folpet phthalimide metabolites in human plasma and urine.

Berthet A, Bouchard M, Schüpfer P, Vernez D, Danuser B, Huynh CK.

Anal Bioanal Chem. 2011 Feb;399(6):2243-55. doi: 10.1007/s00216-010-4601-z. Epub 2011 Jan 13.

PMID:
21229238
32.

Double-dissociation of the catecholaminergic modulation of synaptic transmission in the oval bed nucleus of the stria terminalis.

Krawczyk M, Georges F, Sharma R, Mason X, Berthet A, Bézard E, Dumont EC.

J Neurophysiol. 2011 Jan;105(1):145-53. doi: 10.1152/jn.00710.2010. Epub 2010 Nov 3.

33.

[GRK6, a new therapeutic approach to alleviate L-dopa-induced dyskinesia].

Berthet A, Bézard E.

Med Sci (Paris). 2010 Oct;26(10):800-3. doi: 10.1051/medsci/20102610800. French. No abstract available.

34.

Lentiviral overexpression of GRK6 alleviates L-dopa-induced dyskinesia in experimental Parkinson's disease.

Ahmed MR, Berthet A, Bychkov E, Porras G, Li Q, Bioulac BH, Carl YT, Bloch B, Kook S, Aubert I, Dovero S, Doudnikoff E, Gurevich VV, Gurevich EV, Bezard E.

Sci Transl Med. 2010 Apr 21;2(28):28ra28. doi: 10.1126/scitranslmed.3000664.

35.

Dopamine receptors and L-dopa-induced dyskinesia.

Berthet A, Bezard E.

Parkinsonism Relat Disord. 2009 Dec;15 Suppl 4:S8-12. doi: 10.1016/S1353-8020(09)70827-2. Review.

PMID:
20123563
36.

Impact of biological and environmental variabilities on biological monitoring--an approach using toxicokinetic models.

Berthet A, de Batz A, Tardif R, Charest-Tardif G, Truchon G, Vernez D, Droz PO.

J Occup Environ Hyg. 2010 Mar;7(3):177-84. doi: 10.1080/15459620903530052. Erratum in: J Occup Environ Hyg. 2011 May;8(5):D37-8.

37.

Pharmacological analysis demonstrates dramatic alteration of D1 dopamine receptor neuronal distribution in the rat analog of L-DOPA-induced dyskinesia.

Berthet A, Porras G, Doudnikoff E, Stark H, Cador M, Bezard E, Bloch B.

J Neurosci. 2009 Apr 15;29(15):4829-35. doi: 10.1523/JNEUROSCI.5884-08.2009.

38.

Antagonizing L-type Ca2+ channel reduces development of abnormal involuntary movement in the rat model of L-3,4-dihydroxyphenylalanine-induced dyskinesia.

Schuster S, Doudnikoff E, Rylander D, Berthet A, Aubert I, Ittrich C, Bloch B, Cenci MA, Surmeier DJ, Hengerer B, Bezard E.

Biol Psychiatry. 2009 Mar 15;65(6):518-26. doi: 10.1016/j.biopsych.2008.09.008. Epub 2008 Oct 23.

PMID:
18947822
39.

Sedation with 50% nitrous oxide/oxygen for outpatient dental treatment in individuals with intellectual disability.

Faulks D, Hennequin M, Albecker-Grappe S, Manière MC, Tardieu C, Berthet A, Wolikow M, Droz D, Koscielny S, Onody P.

Dev Med Child Neurol. 2007 Aug;49(8):621-5.

40.

A prospective multicentric trial for effectiveness and tolerance of a N2O/O2 premix used as a sedative drug.

Hennequin M, Manière MC, Albecker-Grappe S, Faulks D, Berthet A, Tardieu C, Droz D, Wolikow M, Koscielny S, Onody P.

J Clin Psychopharmacol. 2004 Oct;24(5):552-4. No abstract available.

PMID:
15349016
41.

[Synergism of the combination of enzymes or surfactants and a phenolic disinfectant on a bacterial biofilm].

Jacquelin LF, Le Magrex E, Brisset L, Carquin J, Berthet A, Choisy C.

Pathol Biol (Paris). 1994 May;42(5):425-31. French.

PMID:
7824307
42.

[From the mixed dentition to the permanent dentition: how to manage space while guiding eruption?].

Jacquelin LF, Berthet A.

Rev Odontostomatol (Paris). 1991 Jul-Aug;20(4):321-9. French.

PMID:
1843555
43.

[Interligamentary anesthesia in pediatric dentistry].

Jacquelin LF, Berthet A.

Inf Dent. 1990 Oct 25;72(37):3449-56. French. No abstract available.

PMID:
2272689
44.

[Physiological resorption of deciduous teeth].

Berthet A, Maquin D.

Rev Orthop Dento Faciale. 1990;24(1):35-49. French. No abstract available.

PMID:
2382085
45.

[The deciduous tooth: therapeutic choices].

Jacquelin LF, Berthet A, Joseph N.

Rev Odontostomatol (Paris). 1989 Sep-Oct;18(5):415-21. French.

PMID:
2639478
46.

[Multidisciplinary treatment of coronal-radicular fractures of permanent teeth in children].

Jacquelin LF, Berthet A, Svoboda JM, Pagin J.

Inf Dent. 1988 Apr 14;70(15):1195-8. French. No abstract available.

PMID:
3246416
47.

[Root changes in deciduous teeth during resorption, therapeutic consequences].

Berthet A, Verchère M.

Rev Odontostomatol (Paris). 1986 Nov-Dec;15(6):463-8. French. No abstract available.

PMID:
3468581
48.

[Radiographic examination in pedodontics: a complex problem].

Berthet A, Gringuillard P, Verchère M.

Rev Odontostomatol (Paris). 1984 Sep-Oct;13(5):321-6. French. No abstract available.

PMID:
6597503
49.

[VDS--ventral derotation spondylodesis--preliminary report on 58 cases].

Zielke K, Berthet A.

Beitr Orthop Traumatol. 1978 Feb;25(2):85-103. German. No abstract available.

PMID:
646769
50.

[Direct communication between Wirsung's duct and the pleura during enzymatic pleurisy. Demonstration by wirsungography].

Rignault D, Tardat M, Berthet A, Pailler JL.

Nouv Presse Med. 1976 Nov 13;5(38):2536-8. French. No abstract available.

PMID:
980765

Supplemental Content

Loading ...
Support Center